Latest News and Press Releases

Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033" report has been added to ...

Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Breast Cancer Therapeutics - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.This global report on Breast Cancer...

Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "HER2 Positive Breast Cancer - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The report encompasses an in-depth...

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Metastatic HR+/HER2 - Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032" report has been added to ResearchAndMarkets.com's...

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...

Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Breast Cancer Drugs Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The breast cancer drugs market size is set to to...

Dublin, April 07, 2023 (GLOBE NEWSWIRE) -- The "HER2 Inhibitors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global her2 inhibitors market is expected...

Dublin, Sept. 27, 2022 (GLOBE NEWSWIRE) -- The "Trastuzumab Biosimilars Global Market Report 2022: By Product, By Indication, By Distribution" report has been added to ResearchAndMarkets.com's...

Dublin, July 01, 2022 (GLOBE NEWSWIRE) -- The "HER2 Inhibitors Global Market Report 2022: By Treatment, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering. This...

Dublin, March 09, 2022 (GLOBE NEWSWIRE) -- The "Global Breast Cancer Drug Market (2021-2026) by Drug Type, Distribution Channel, Geography, Competitive Analysis and the Impact of Covid-19 with...